Immunohistochemistry evaluated levels of HIF-1α, pimonidazole, cleaved-caspase3 and an oxidized base, 8-OHdG, in xenograft tumours that underwent control or YC-1 + GI treatments (Fig. 7e). Here, HIF1A is linked to neoplasm.